Effects of heparin and aspirin on circulating P-selectin, E-selectin and von Willebrand Factor levels in healthy men

Atherosclerosis

Volumn 155, Issue 2, 2001, Pages 389-393

  Pernerstorfer, Thomas ^a   Eichler, Hans Georg ^a   Stohlawetz, Petra ^a   Speiser, Wolfgang ^a   Jilma, Bernd ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aspirin; Circulating; E selectin; Heparin; P selectin; Soluble; Von Willebrand factor

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HEPARIN; PADGEM PROTEIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD CLOT LYSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG INFUSION; HUMAN; MALE; NORMAL HUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ANOMALY; THROMBOCYTE COUNT; THROMBOCYTE RELEASE REACTION;

ADULT; ANTICOAGULANTS; ASPIRIN; BIOLOGICAL MARKERS; E-SELECTIN; HEPARIN; HUMANS; MALE; P-SELECTIN; PARTIAL THROMBOPLASTIN TIME; PLATELET AGGREGATION INHIBITORS; REFERENCE VALUES; THROMBIN; VON WILLEBRAND FACTOR;

EID: 0035089711     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00566-9     Document Type: Article

References (36)

1. Endothelial and leukocyte adhesion molecules in inflammation and disease
2. Von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis
3. Soluble P-selectin in atherosclerosis: A comparison with endothelial cell and platelet markers
4. Hypothesis: Is soluble P-selectin a new marker of platelet activation?
5. Re-expression of functional p selectin molecules on the endothelial cell surface by repeated stimulation with thrombin
6. Effects of histamine and nitric oxide synthase inhibition on plasma levels of von Willebrand factor antigen
7. Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease
8. Effects of estradiol on circulating P-selectin
9. The origin of P-selectin as a circulating plasma protein
10. Differential induction of P-selectin expression on platelets by two cell separators during plateletpheresis and gender effects on the release of soluble P-selectin
11. Serum concentrations of E-selectin, P-selectin, ICAM-1 and interleukin 6 in acute leukaemia patients with chemotherapy- induced leucopenia and bacterial infections
12. Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome
13. Kinetics of circulating selectin levels during bone marrow aplasia
14. Von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia
15. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk In Communities (ARIC) study
16. Selectins in the HIT syndrome: Pathophysiologic role and therapeutic modulation
17. Aspirin, heparin, or both to treat acute unstable angina
18. Low dose aspirin does not prevent platelet activation in healthy smokers
19. Effects of endothelin-1 on circulating adhesion molecules in man
20. Effects of desmopressin on circulating P-selectin
21. Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor
22. Impairment by heparin of primary haemostasis and platelet [14C]5-hydroxytryptamine release
23. Soluble P-selectin is released into the coronary circulation after coronary spasm
24. Increased soluble form of P-selectin in patients with unstable angina
25. Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents
26. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro
27. P-Selectin and platelet clearance
28. In vivo tracking of platelets: Circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function
29. Effects of nitric oxide on platelet activation during plateletpheresis, and in vivo tracking of biotinylated platelets in humans
30. Heparin in inflammation: Potential therapeutic applications beyond anticoagulation
31. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
32. Association of coagulation factors and inhibitors with carotid artery atherosclerosis. Early results of the Atherosclerosis Risk in Communities (ARIC) Study
33. The factor VIII complex in atherosclerosis: Effects of aspirin
34. Aspirin
35. Biosynthesis of von Willebrand protein by human endothelial cells: Processing steps and their intracellular localization
36. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock